In <i>cut(ue)</i>-Gal4 > <i>lov</i> RNAi tracheae, cells of DT Tr10 are smaller, more numerous, and show decreased DNA content compared to adjacent cells in DT Tr9. by Fanli Zhou (3142398)

Decreased REG4 and increased p21^Cip1/WAF1, p27^Kip1, and cyclin D1 expression in ADAM9 knockdown prostate cancer cells. by Che-Ming Liu (102604)

“…<p>(a) Quantitative PCR confirmed the decrease of REG4 mRNA and increase of CD33 mRNA. (b) Overexpression of REG4 decreased p21^Cip1/WAF1 expression under FBS starvation conditions in PC3_shADAM9. …”

F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

“…<p>A.) Human M2 macrophages (2.5x10⁴) were co-cultured with Raji tumor cells (5x10⁴) and exposed to mAb’s for 4 hours before Raji luminescence was quantified (two tailed t-test; 1H9, p = 0.021; F05, p = 0.011). …”

Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects by Xiaopeng Peng (9136955)

“…Importantly, the combination of <b>NT-6</b> with a small-molecule PD-L1 inhibitor NP-19 decreased tumor burden significantly (TGI% = 77.6%). …”

Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects by Xiaopeng Peng (9136955)

“…Importantly, the combination of <b>NT-6</b> with a small-molecule PD-L1 inhibitor NP-19 decreased tumor burden significantly (TGI% = 77.6%). …”

Mean seedling length of mung bean genotypes grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean total protein contents of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean values for GPX activity in mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean relative water content of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Old rats present impaired wound healing compared to young rats. by María Paz Saldías (4430032)

There was no effect of statins on numbers of new neurons. by Shuk C. Tsoi (21192243)

As a result of the clean vehicle rebate project, net local SO₂ and NO_X emissions decrease more for least disadvantaged communities than for disadvantaged comm... by Jaye Mejía-Duwan (15401425)

NS affects the PI3K/AKT/mTOR pathway in RAW264.7 cells. by Yihua Wang (491766)

Omeprazole (Ome) decreases IL-4-stimulated RNA Pol II binding to the endogenous eotaxin-3 promoter in (A) EoE1-T and (B) EoE2-T cells. by Xi Zhang (83736)

Presentation_1_1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model.pdf by Kayleigh Slater (6273734)

“…In an orthotopic, cell line-derived xenograft model of MUM, 1,4-dihydroxy quininib administered intraperitoneally at 25 mg/kg significantly decreases ATP5B expression (p = 0.03), a marker of oxidative phosphorylation. …”

Effects of cerulenin on GSC viability and invasion. by Yuki Yasumoto (685821)

Molecular profiling by HTG after Parsortix PR1 enrichment. by Evan N. Cohen (9557714)

“…Epithelial genes including <i>ERBB2</i> and <i>KRT18</i> are expressed by neat SKBR3 cells and are decreasingly common as the number of cells spiked into blood decreases prior to Parsortix PR1 enrichment and HTG assessment. …”

Fig 7 - by Yi-xiao Liu (14769126)

Comparison of olfactory bulb neurogenesis in mThy1 & PDGF transgenic mice. by Sebastian R. Schreglmann (737386)

“…In the granular cell layer, the number of new neurons was decreased in PDGF animals, while mThy1 animals display an unaltered neurogenesis. …”

Polymorphisms in <i>CYP1B1</i>, <i>CYP3A5</i>, <i>GSTT1</i>, and <i>SULT1A1</i> Are Associated with Early Age Acute Leukemia by Bruno Almeida Lopes (740876)

“…Using data from the Brazilian Collaborative Study Group of Infant Acute Leukemia (2000–2012), 350 cases and 404 age-matched controls and 134 mothers of cases and controls were genotyped to explore polymorphisms in genes of the estrogen metabolism pathway: <i>CYP1B1</i> (c.1294C>G, rs1056836), <i>CYP3A4</i> (c.-392A>G, rs2740574), <i>CYP3A5</i> (c.219-237G>A, rs776746), <i>GSTM1/GSTT1</i> deletions, and <i>SULT1A1</i> (c.638G>A, rs9282861; and c.667A>G, rs1801030). …”